资讯

Phathom Pharmaceuticals announced FDA approval of a Citizen Petition extending VOQUEZNA® exclusivity to May 3, 2032. Quiver AI Summary. Phathom Pharmaceuticals, Inc. announced that the FDA has ...
The Council is ready to begin negotiations with the European Parliament, having agreed its position on new rules that aim to make the EU’s pharmaceutical sector fairer and more competitive. The ...
Monitoring the amount of active pharmaceutical ingredient (API) in finished dosage form is important to ensure the content uniformity of the product. In this report, we summarize the development and ...
On June 2, H.C. Wainwright’s Patrick Trucchio reiterated his Buy rating on Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and raised his price target from $400 to $500.
Trump’s tariff threat exposes China’s tight grip on the global pharmaceuticals industry ...
Hyperspectral imaging serves as a powerful tool for environmental studies, enabling the capture of significant properties in the objects being analyzed. These hidden properties may not be discernible ...
“Pharmageddon,” a provocative documentary directed by Donal O’Neill and produced by British cardiologist Dr. Aseem Malhotra, was launched recently on the sidelines of the Cannes Film Festival.
Hyperspectral imagery (HSI) contains hundreds of bands, which provide a wealth of spectral information and enable better characterization of features. However, the excessive dimensionality also poses ...
Although Trump had not announced any pharmaceutical tariffs as of May 22, he “promised he will disclose pharma-specific tariffs very soon,” said Karen Anderson, a health care analyst with the ...
This stock is Vertex Pharmaceuticals (VRTX-1.65%), a biotech that's delivered a long track record of growth and profitability thanks to its leadership in the cystic fibrosis (CF) treatment market.
Hyperspectral imaging with enhanced darkfield microscopy (HSI-M) possesses unique advantages in its simplicity and non-invasiveness. In consideration of the urgent need for profound knowledge on the ...